Furthermore, behavioral performance of anxiety and depression, learning and memory disturbances, cytokine levels in prostates and cerebrospinal fluid (CSF), and alterations of ERK1/2 signaling were studied in specific brain areas in a rodent model of CP/CPPS. This evidence concerns the gene MAPK3 and depressive symptom measurement.